1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of the Markets/Categories Covered 11
3.1 Anesthesia and Respiratory Devices 11
3.1.1 Respiratory Devices 11
4 Company Snapshot 12
4.1 Key Information 12
4.2 Company Overview 12
4.3 Financial Performance 12
4.4 Industry Outlook – Anesthesia and Respiratory Devices 12
4.5 SWOT Snapshot 13
5 Business Description 14
5.1 Business Overview 14
5.2 AL Welding Group 14
5.2.1 Overview 14
5.2.2 Financials 14
5.2.3 Capital Expenditure 14
5.2.4 Market View 14
5.2.5 Key Strategies 14
5.3 Engineering and Construction 14
5.3.1 Overview 14
5.3.2 Financials 15
5.3.3 Capital Expenditure 15
5.3.4 Market View 15
5.3.5 Key Strategies 15
5.4 Gas and Services 15
5.4.1 Overview 15
5.4.2 Financials 15
5.4.3 Capital Expenditure 15
5.4.4 Market View 16
5.4.5 Key Strategies 16
5.5 Other activities 16
5.5.1 Overview 16
5.5.2 Financials 16
5.5.3 Capital Expenditure 16
5.5.4 Market View 16
5.5.5 Key Strategies 16
5.6 Major Products and Services 17
5.6.1 Overview 17
6 History 18
7 Business Strategy 21
7.1 Mission Statement 21
7.2 Strategy 21
7.3 Corporate Social Responsibility 21
7.3.1 Overview 21
8 Value Chain Analysis 23
8.1 Manufacturing 23
8.1.1 In House Manufacturing 23
8.1.2 Outsourcing 23
8.2 Product Development 24
8.2.1 Regulatory Approvals 24
8.2.2 Clinical Trials 24
8.2.3 Research and Development 24
8.3 Sales and Marketing 24
8.3.1 Partnerships and Alliances 24
8.3.2 Licensing Agreements 24
8.3.3 E-distribution 24
9 SWOT Analysis 25
9.1 Overview 25
9.2 AIR LIQUIDE Strengths 25
9.2.1 Fruitful research and development 25
9.2.2 Wide range of products and services 25
9.2.3 Broad operational network 26
9.3 AIR LIQUIDE Weaknesses 26
9.3.1 Engineering and construction segment’s poor performance 26
9.3.2 Loss of reputation 26
9.4 AIR LIQUIDE Opportunities 26
9.4.1 Growing Middle East and Asian market 26
9.4.2 Investment in hydrogen sector 26
9.4.3 Acquisitions 26
9.5 AIR LIQUIDE Threats 27
9.5.1 Kyoto Protocol 27
9.5.2 Rise in fuel prices 27
9.5.3 Consolidation 27
10 Competitors 28
11 AIR LIQUIDE Medical Equipment Market Share Analysis (2007) 29
11.1 AIR LIQUIDE, Anesthesia and Respiratory Devices, Global, Market Share (2007) 29
11.2 AIR LIQUIDE, Anesthesia and Respiratory Devices, Europe, Market Share (2007) 30
11.3 AIR LIQUIDE, Anesthesia and Respiratory Devices, North America, Market Share (2007) 31
11.4 AIR LIQUIDE, Anesthesia and Respiratory Devices, SCA, Market Share (2007) 31
12 Revenue Analysis 32
12.1 Revenue by Segment 32
12.2 Revenue by Geography 32
13 Financial and Operational Review 34
13.1 Financial Statements 34
13.2 Financial Ratios 35
14 Key Employees 36
15 Key Employee Biographies 37
16 Company Statement 38
17 Locations And Subsidiaries 40
17.1 Head Office 40
17.2 Other Locations & Subsidiaries 40
18 Financial Deals Landscape 42
18.1 Acquisition 42
18.1.1 Air Liquide acquires 100% of Japan Air Gases 42
18.1.2 Air Liquide Acquires Linde Gas 43
18.1.3 American Air Liquide Holdings Acquires Scott Specialty Gases 45
18.1.4 Air Liquide Acquires Remaining Stake In Japan Air Gases 46
18.1.5 Air Liquide Acquires Nord Service Projects 48
18.1.6 Vitalaire Acquires Braun Meditec 49
18.1.7 Air Liquide Acquires Aiolos Medical 50
19 Recent Developments 52
19.1 Strategy And Business Planning 52
19.1.1 Jan 23, 2007: Air Liquide Opens New R&D And Technology Center 52
19.2 Financial Announcements 52
19.2.1 Aug 04, 2008: Air Liquide Reports 1H 2008 Results 52
19.2.2 Jan 30, 2008: Air Liquide Declares Q4 2007 Results 54
19.2.3 Oct 25, 2007: Air Liquide Declares Q3 2007 Results 54
19.2.4 Aug 03, 2007: Air Liquide Declares H1 2007 Results 56
19.2.5 Apr 25, 2007: Air Liquide Declares Q1 2007 Results 58
19.2.6 Feb 27, 2007: Air Liquide Declares 2006 Results 59
19.3 Corporate Communications 60
19.3.1 Jul 16, 2008: Air Liquide Appoints Group Vice President Finance And Administration 60
19.4 Other Significant Developments 61
19.4.1 Nov 12, 2007: Air Liquide Takes Part In Disabled Week In France 61
20 Appendix 62
20.1 Global Markets Direct Research Methodology 62
20.2 Coverage 63
20.3 Secondary Research 63
20.4 Primary Research 64
20.5 Models 64
20.6 Forecasts 65
20.7 Expert Panels 65
20.8 Market Revenue Chapters 65
20.8.1 Abbreviations 65
20.8.2 Currency Conversions 66
20.9 About Global Markets Direct 67
20.10 Contact Us 67
20.11 Disclaimer 67
[Fade out table of contents]